1-Cyclohexyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 250mg

4-Fluoro-5-methyl-1H-pyrrolo[2,3-b]pyridine, 97%, 25mg

1-(2-Hydroxy-6-methoxyphenyl)ethanone, 95.0%, 1g

6-Bromo-3-chloro-2-fluorobenzaldehyde, 95.0%, 25g

2-(5-Chloro-1H-indol-3-yl)acetic acid, 95.0%, 5g

N-(5,6,7,8-TETRAHYDRONAPHTHALEN-1-YL)ACETAMIDE, 95.0%, 250mg

(E)-2-((1-BENZYL-1,2,3,6-TETRAHYDROPYRIDIN-4-YL)METHYLENE)-5,6-DIMETHOXY-2,3-DIHYDRO-1H-INDEN-1-ONE, 97%, 250mg

5-Amino-1-(3-chloro-phenyl)-1 H -pyrazole-4-carboxylic acid, 99.0%, 1g

Puerta de fundición de gel PROfessional III, 1 par

4-Trifluoromethylphenylglyoxal hydrate, 95.0%, 5g

Notoginsenoside R1>98.0%(HPLC)10mg

2-(4-Bromo-2-methoxyphenoxy)ethan-1-ol, 95+%, 1g

Methyl (S)-4-benzyl-5-oxo-morpholine-3-carboxylate, 97.0%, 10g